Advertisement

Understanding Disparities, Clinical Trials, Support and More for Patients with Multiple Myeloma

As part of its Speaking Out video series,CURE® spoke with Dr. Joseph Mikhael and Robin Tuohy on behalf of the International Myeloma Foundation.

EP. 1: Finding Support During a Multiple Myeloma Diagnosis

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their vice president of support, Robin Tuohy about the importance of support for patients with multiple myeloma, and their caregivers.

EP. 2: The Basics of Clinical Trials for Patients with Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about clinical trials for patients with multiple myeloma.

EP. 3: Spotlighting Disparities in Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about disparities in the multiple myeloma space.

EP. 4: Treating, Monitoring and Understanding Myeloma Precursors, MGUS and Smoldering Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the precursors to multiple myeloma, MGUS and smoldering myeloma.

EP. 5: Managing the Risk of Infection for Patients with Multiple Myeloma

November 21st 2022

As a part of its “Speaking Out” video series, on behalf of the International Myeloma Foundation, CURE® spoke with their chief medical officer, Dr. Joseph Mikhael about the risk of infection for patients with multiple myeloma.

Advertisement
Advertisement